Emily Lin

Title: Emily Lin - Innovator in Immunocytochemistry and In-Situ Hybridization

Introduction

Emily Lin is a prominent inventor based in San Jose, CA. She has made significant contributions to the field of immunocytochemistry and in-situ hybridization. Her innovative methods have the potential to enhance the understanding of cellular characteristics.

Latest Patents

Emily Lin holds a patent for "High efficiency methods for combined immunocytochemistry and in-situ hybridization." This invention provides a high-efficiency method for simultaneously determining a cell's phenotype and genotype. The method involves contacting a cell with an antigen-specific antibody bound to a ligand, followed by the use of a polynucleotide probe to form a complex with the nucleic acid in the cell. The presence of the anti-ligand is correlated with the presence of the antigen, while the probe-nucleic acid complex indicates the presence of nucleic acid in the cell. This innovative approach streamlines the process of cellular analysis.

Career Highlights

Emily Lin is currently associated with Applied Imaging Corporation, where she continues to develop her groundbreaking techniques. Her work has garnered attention for its potential applications in various biological and medical fields.

Collaborations

Emily has collaborated with notable colleagues, including Simon Goldbard and Tsai-Hsia Hong. Their combined expertise contributes to the advancement of research in their respective areas.

Conclusion

Emily Lin is a trailblazer in the field of immunocytochemistry and in-situ hybridization, with her innovative methods paving the way for future advancements in cellular analysis. Her contributions are invaluable to the scientific community.